Connection

David Priest to Quinazolines

This is a "connection" page, showing publications David Priest has written about Quinazolines.
Connection Strength

0.194
  1. The role of cellular folates in the enhancement of activity of the thymidylate synthase inhibitor 10-propargyl-5,8-dideazafolate against hepatoma cells in vitro by inhibitors of dihydrofolate reductase. J Biol Chem. 1989 Jun 25; 264(18):10685-92.
    View in: PubMed
    Score: 0.080
  2. The enhancement of the activity of 10-propargyl-5,8-dideazafolate and 5,10-dideazatetrahydrofolate by inhibitors of dihydrofolate reductase. Adv Enzyme Regul. 1989; 28:13-21.
    View in: PubMed
    Score: 0.077
  3. Role of substrate depletion in the inhibition of thymidylate biosynthesis by the dihydrofolate reductase inhibitor trimetrexate in cultured hepatoma cells. Cancer Res. 1990 Jul 01; 50(13):3979-84.
    View in: PubMed
    Score: 0.021
  4. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors. Cancer Res. 2001 May 01; 61(9):3675-81.
    View in: PubMed
    Score: 0.011
  5. Micellar high-performance liquid chromatographic determination of folylpolyglutamate hydrolase activity. J Chromatogr. 1986 Apr 23; 357(1):183-9.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.